AstraZeneca AstraZeneca warns German reforms could push pharma launches and investment out of Europe AstraZeneca CEO warns that pharma may avoid launching new medicines in Europe’s largest market
Inside EU Health Inside EU Health: Fallout for Várhelyi; US trade barrier report; cost of Long COVID; 40% of 65+ consider themselves healthy; gaps in tobacco and nicotine rules Fallout for Várhelyi from Hungarian elections; US trade barrier report; Long COVID could cost as much as €115 billion; perceived health; EU evaluation of tobacco and nicotine framework; Belgian court triggers vaccine blame game
Germany Germany sets out 66 possible reforms to cut health spending Germany has presented a 66-option health reform plan, leaving politicians to decide what and where to cut
